NCT01639066View on ClinicalTrials.gov

Tenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis B

PHASE4CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

September 25, 2012

Primary Completion Date

September 22, 2017

Study Completion Date

September 22, 2017

Conditions
Chronic Viral Hepatitis B Without Delta-agent
Interventions
DRUG

Tenofovir

Tenofovir 300mg daily Oral

DRUG

Entecavir

Entecavir 1 mg daily Oral

DRUG

Tenofovir

Tenofovir 300mg daily Oral

Trial Locations (1)

138-736

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Samsung Medical Center

OTHER

collaborator

Konkuk University Medical Center

OTHER

collaborator

Korea University Guro Hospital

OTHER

collaborator

Seoul National University Hospital

OTHER

lead

Asan Medical Center

OTHER